These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 16001640

  • 1. Decreased cell-mediated immune status in colorectal cancer patients with hepatic metastasis.
    Shimizu H, Ito H, Kimura F, Togawa A, Yoshidome H, Ohtsuka M, Kato A, Nukui Y, Miyazaki M.
    Hepatogastroenterology; 2005; 52(64):1106-9. PubMed ID: 16001640
    [Abstract] [Full Text] [Related]

  • 2. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J, Lauerova L, Janakova L, Talac R, Simickova M, Nekulova M, Mikulikova I, Kovarik J, Sheard M.
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [Abstract] [Full Text] [Related]

  • 3. [Effect of acupuncture on the activity of the peripheral blood T lymphocyte subsets and NK cells in patients with colorectal cancer liver metastasis].
    Zhao CL, Peng LJ, Zhang ZL, Zhang T, Li HM.
    Zhongguo Zhen Jiu; 2010 Jan; 30(1):10-2. PubMed ID: 20353106
    [Abstract] [Full Text] [Related]

  • 4. [Diagnosis of cancer using lymphocyte electrophoresis (3): Electrophoretic mobility, interleukin 1 and prostaglandin E2 productions of monocytes in peripheral blood of cancer patients].
    Shimizu M, Sekine K, Iwaguchi T, Kataoka T, Mori T.
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):639-43. PubMed ID: 2321984
    [Abstract] [Full Text] [Related]

  • 5. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
    Nagamine I, Yamaguchi Y, Ohara M, Ikeda T, Okada M.
    Hiroshima J Med Sci; 2009 Mar; 58(1):37-44. PubMed ID: 19400555
    [Abstract] [Full Text] [Related]

  • 6. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
    Hu H, Sun L, Guo C, Liu Q, Zhou Z, Peng L, Pan J, Yu L, Lou J, Yang Z, Zhao P, Ran Y.
    Clin Cancer Res; 2009 Sep 01; 15(17):5485-93. PubMed ID: 19706805
    [Abstract] [Full Text] [Related]

  • 7. Immunoresponsiveness of cancer patients: effect of blood transfusion and immune reactivity of tumor infiltrating lymphocytes.
    Quintiliani L, Iudicone P, Di Girolamo M, Buzzonetti A, Guglielmetti M, Lapponi P, Traietti P, Monno D, Giuliani E.
    Cancer Detect Prev; 1995 Sep 01; 19(6):518-26. PubMed ID: 8925521
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer.
    Qiu H, Xiao-Jun W, Zhi-Wei Z, Gong C, Guo-Qiang W, Li-Yi Z, Yuan-Fang L, Rajiv-Prasad K.
    Hepatogastroenterology; 2009 Sep 01; 56(94-95):1310-5. PubMed ID: 19950782
    [Abstract] [Full Text] [Related]

  • 14. [A study on correlation of hepatic metastasis of colorectal cancer to vascular endothelial growth factor, angiopoietin-2, and fibronectin].
    Liang XY, Wang T, Yang XD, Qiu YJ, Zhu LW, Wang PZ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jan 01; 8(1):20-3. PubMed ID: 16148991
    [Abstract] [Full Text] [Related]

  • 15. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers.
    Romano F, Uggeri F, Crippa S, Di Stefano G, Scotti M, Scaini A, Caprotti R, Uggeri F.
    J Exp Clin Cancer Res; 2004 Jun 01; 23(2):195-200. PubMed ID: 15354402
    [Abstract] [Full Text] [Related]

  • 16. Rofecoxib has different effects on chemokine production in colorectal cancer cells and tumor immune splenocytes.
    Walmesley AJ, Zweiri J, Christmas SE, Watson AJ.
    J Immunother; 2007 Sep 01; 30(6):614-23. PubMed ID: 17667525
    [Abstract] [Full Text] [Related]

  • 17. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
    Wagner P, Koch M, Nummer D, Palm S, Galindo L, Autenrieth D, Rahbari N, Schmitz-Winnenthal FH, Schirrmacher V, Büchler MW, Beckhove P, Weitz J.
    Ann Surg Oncol; 2008 Aug 01; 15(8):2310-7. PubMed ID: 18521684
    [Abstract] [Full Text] [Related]

  • 18. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
    Varker KA, Kondadasula SV, Go MR, Lesinski GB, Ghosh-Berkebile R, Lehman A, Monk JP, Olencki T, Kendra K, Carson WE.
    Clin Cancer Res; 2006 Oct 01; 12(19):5850-8. PubMed ID: 17020993
    [Abstract] [Full Text] [Related]

  • 19. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.
    Maccalli C, Di Cristanziano V, Fodale V, Corsi D, D'Agostino G, Petrangeli V, Laurenti L, Guida S, Mazzocchi A, Arienti F, Perrone MP, Castelli C, Rivoltini L, Zagonel V, Tartaglia M, Parmiani G, Belardelli F.
    Clin Cancer Res; 2008 Nov 15; 14(22):7292-303. PubMed ID: 18974390
    [Abstract] [Full Text] [Related]

  • 20. Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer.
    Chen X, Hu ZP, Yang XX, Huang M, Gao Y, Tang W, Chan SY, Dai X, Ye J, Ho PC, Duan W, Yang HY, Zhu YZ, Zhou SF.
    Int Immunopharmacol; 2006 Mar 15; 6(3):499-508. PubMed ID: 16428086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.